Search for dissertations about: "immune risk"
Showing result 1 - 5 of 681 swedish dissertations containing the words immune risk.
-
1. The Immune System in the Oldest-Old : Clinical and Immunological Studies in the NONA Immune Cohort
Abstract : The oldest-old (people aged 80 or older) constituted 5 % of the population in Sweden in 2000, an increase from 1.5 % fifty years earlier. The immune system undergoes dramatic changes at high age, sometimes referred to as “immunosenescence”. READ MORE
-
2. Methotrexate and Risk of Cutaneous Melanoma
Abstract : Methotrexate (MTX) is an anti-inflammatory and immunosuppressive drug commonly used to treat psoriasis, psoriatic arthritis and rheumatoid arthritis. Cutaneous malignant melanoma (CMM) is a common and dangerous type of skin cancer and in recent decades a noteworthy increase in incidence has been observed. READ MORE
-
3. Risk and prognostic factors for malignant glioma
Abstract : Background: Glioblastoma is the most common and aggressive type of glioma and associated with poor prognosis. Apart from ionizing radiation and some rare genetic disorders, few aetiological factors have been identified for primary brain tumours. READ MORE
-
4. Effects of Complement Opsonization of HIV on Dendritic Cells : and Implications for the Immune Response
Abstract : Dendritic cells are key players during HIV pathogenesis, and shape both the immediate immune response at the site of infection as well as directing the adaptive immune response against the virus. HIV has developed a plethora of immune evasion mechanisms that hijack dendritic cell functions, suppressing their ability to mount an accurate immune response and exploiting them for efficient viral transfer to target T cells. READ MORE
-
5. Immune cell infiltration and prognosis in colorectal cancer
Abstract : Background: Colorectal cancer (CRC) is globally the second most common form of cancer among women, and third in men. It is also one of the most common causes of cancer-related death in high-income countries. Surgical resection is the basis for curative therapy but still almost half of the patients die from metastatic disease. READ MORE